SYNTHESIS OF N-4-METHOXYBENZOYL-N'-PHENYLUREA COMPOUND AND ACTIVITY TEST OF ANTICANCER AGAINST HeLa CELL LINE

Journal Title: World Journal of Pharmaceutical Research - Year 2018, Vol 7, Issue 4

Abstract

Research in the search for cancer drug compounds continues to be developed, considering that specific anticancer compound has not been obtained. Some of the urea derivative compounds are also being developed in the search for an anti-cancer compound which is potent with minimal side effects. Related to the explanation above, a urea derivative, which is N-phenylurea, would like to be developed. It would be reacted with 4-methoxybenzoyl chloride, thus N-4- methoxybenzoyl-N'-phenylurea compound would be obtained. The synthesis of N-4-methoxybenzoyl-N'-phenylurea was carried out by Schotten-Baumman method that had been modified, and then a test of purity was done by thin layer chromatography using 3 different kinds of eluent. The next phase was structure characterization which was carried out by using UV and IR spectrophotometry, then 1H-NMR spectrometry also MS, so that the structure from N-4- methoxybenzoyl-N'-phenylurea would be obtained. Anticancer activation test was conducted on HeLa cell line by using MTT assay, and the value of IC50 would be obtained. The compound that has been successfully synthesized is N-4-methoxybenzoyl-N'-phenylurea, with a yield of 51,23%. The purity test of N-4-methoxybenzoyl-N'-phenylurea was done by thin layer chromatography with 3 different types of eluent (hexane: ethyl acetate: methanol = 2: 3: 1; Hexane: acetone = 4: 2; Hexane: ethyl acetate = 4: 2) one single spot was obtained, which its value of Rf is different than the original compound, N-phenylurea. While the melting point of the compound is 158oC, thus it was seen that the compound has been formed and was different from the original compound, N-phenylurea. Anticancer activation test has been performed with MTT assay method by using HeLa cell line, the result obtained of IC50 is 6.50 mM more active than hydroxyurea is 170.57 mM as a standard. The conclusion is that N-4-methoxybenzoyl-N'phenylurea, have been successfully synthesized and has anticancer activity.

Authors and Affiliations

Bambang Tri Purwanto

Keywords

Related Articles

EPIDEMIOLOGY OF VITILIGO AND ASSOCIATED AUTOIMMUNE DISEASES AMONG PATIENTS ATTENDING DERMATOLOGY CLINICS IN AL-MADINA 2016 -2017

Background: Vitiligo is a common skin disorder that affects 1% of the whole world population, little is known about vitiligo prevalence and it is subtypes in Al Madinah, Saudi Arabia. Objective: To estimate the prevalenc...

GAS CHROMATOGRAPHY-MASS SPECTROMETRY (GC-MS) ANALYSIS OF PHYTOCOMPONENTS IN THE ROOT, STEM BARK AND LEAF OF VERNONIA AMYGDALINA

Vernonia amygdalina is a medicinal plant widely used in traditional medicine in Africa and Asia for the treatment of ailments such as diabetes, inflammation, microbial infections and it has hypoglycaemic properties. The...

WILSON DISEASE-AN OVERVIEW

Wilson disease is a rare inherited disorder that prevents the body from getting rid of extra copper. Our body needs a small amount of copper from food to stay healthy. Too much copper is poisonous. The condition is due t...

A REVIEW ON ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF VALGANCICLOVIR HYDROCHLORIDE

Many theories have proposed to explain the Analytical method development and validation of Valganciclovir hydrochloride. Although the literature survey covers a wide variety of such theories, so the development of sound...

PHYTOCHEMICAL PROFILING OF ETHANOLIC FLOWER EXTRACT OF HIBISCUS ROSA-SINENSIS AND EVALUATION OF ITS ANTIOXIDANT POTENTIAL

The medicinal plant is the greatest high-class foundation of life redeemable drugs for the mainstream of the flora and fauna population. They bear to be a significant beneficial support for improving the illnesses of the...

Download PDF file
  • EP ID EP620508
  • DOI -
  • Views 138
  • Downloads 0

How To Cite

Bambang Tri Purwanto (2018). SYNTHESIS OF N-4-METHOXYBENZOYL-N'-PHENYLUREA COMPOUND AND ACTIVITY TEST OF ANTICANCER AGAINST HeLa CELL LINE. World Journal of Pharmaceutical Research, 7(4), 56-69. https://europub.co.uk./articles/-A-620508